¥Ð¥Ê¥Ê¤Ï¿©¤Ù¤Æ¤¤¤¤¡©¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¤¬»éËôΡÊMASLD¡Ë¤ËÍ¿¤¨¤ë±Æ¶Á¤È¤Ï

¼Ì¿¿³ÈÂç (Á´2Ëç)

¡Ö»éËôΤǤâ¥Ð¥Ê¥Ê¤Ï¿©¤Ù¤Æ¤¤¤¤¤Î¡©¡×

¤½¤¦µ¿Ìä¤Ë»×¤¦Êý¤Ï¾¯¤Ê¤¯¤¢¤ê¤Þ¤»¤ó¡£»éËôΡÊMASLD¡Ë¤Ï¡¢¤«¤Ä¤Æ¡ÖNAFLD¡ÊÈ󥢥륳¡¼¥ëÀ­»éËÃÀ­´Î¼À´µ¡Ë¡×¤È¸Æ¤Ð¤ì¤Æ¤¤¤Þ¤·¤¿¤¬¡¢2023ǯ¤«¤é¤ÏÂå¼Õ°Û¾ï¤òÁ°Äó¤È¤·¤¿¡ÖMASLD¡§Metabolic dysfunction-associated steatotic liver disease¡×¤È¤·¤ÆÄêµÁ¤¬ºþ¿·¤µ¤ì¤Þ¤·¤¿¡£

»éËôΤμ£ÎŤǤϡ¢Åü¼Á¡¦»é¼Á¤Î²á¾êÀݼè¤ò¹µ¤¨¤ë¤³¤È¤¬´ðËܤǤ¹¤¬¡¢¥Ð¥Ê¥Ê¤Ï¡È²Ìʪ¡á²ÌÅü¤¬Â¿¤¤¡É¤È¤·¤Æ·É±ó¤µ¤ì¤¬¤Á¤Ç¤¹¡£°ìÊý¤Ç¡¢¥Ð¥Ê¥Ê¡¢¤È¤¯¤Ë̤½Ï¤Ê¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¤Ë¤Ï¡¢¥ì¥¸¥¹¥¿¥ó¥È¥¹¥¿¡¼¥Á¡ÊÆñ¾Ã²½À­¤Ç¤ó¤×¤ó¡Ë¤¬Ë­É٤˴ޤޤ졢»éËôΤβþÁ±¤Ë´óÍ¿¤¹¤ë²ÄǽÀ­¤¬ÃíÌܤµ¤ì¤Æ¤¤¤Þ¤¹¡£

Ëܵ­»ö¤Ç¤Ï¡¢¥Ð¥Ê¥Ê¤Î¼ïÎà¤ÈÀ®½ÏÅ٤ˤè¤ë±Æ¶Á¤Î°ã¤¤¡¢»éËôΤȤδط¸À­¤Î²Ê³ØÅª¥¨¥Ó¥Ç¥ó¥¹¡¢¿©¤ÙÊý¤ÎÃí°ÕÅÀ¤Ë¤Ä¤¤¤Æ¾Ü¤·¤¯²òÀ⤷¤Þ¤¹¡£

¡Ú´ØÏ¢µ­»ö¡Û¥À¥¤¥¨¥Ã¥ÈÃæ¤ÎÊý¤Ë¤ª´«¤á¡ª¥Ð¥Ê¥Ê¤ä¥³¡¼¥Ò¡¼¤Ê¤É¿©Íߤ¬¤ª¤µ¤Þ¤ê¤ä¤¹¤¤¿©ºà£´¤Ä

¢£¥Ð¥Ê¥Ê¤ÎÀ®½ÏÅ٤ȱÉÍÜÀ®Ê¬¤ÎÊѲ½

¥Ð¥Ê¥Ê¤Ï½Ï¤¹¤Ë¤Ä¤ì¤Æ°Ê²¼¤Î¤è¤¦¤Ë±ÉÍÜÁǤ¬ÊѲ½¤·¤Þ¤¹¡§

À®½ÏÅÙ¡¿¼ç¤ÊÅü¼Á¤Î¼ïÎà¡¿·ìÅüÃͤؤαƶÁ¡¿¥ì¥¸¥¹¥¿¥ó¥È¥¹¥¿¡¼¥ÁÎÌ
¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¡¿¥ì¥¸¥¹¥¿¥ó¥È¥¹¥¿¡¼¥Á¿¤á¡¿ÄãGI¡¿Â¿¤¤¡Ê40¡Á50%¡Ë
²«¿§¥Ð¥Ê¥Ê¡¿¥Ç¥ó¥×¥ó¸º¾¯¡¦¥·¥çÅüÁý²Ã¡¿ÃæGI¡¿¸º¾¯¡Ê10¡Á15%¡Ë
´°½Ï¥Ð¥Ê¥Ê¡Ê¹õÈ䢤ê¡Ë¡¿Ã±ÅüÎàÁý²Ã¡¿¹âGI¡¿¶Ë¾¯¡Ê5%̤Ëþ¡Ë

¤Ä¤Þ¤ê¡¢»éËôΤÎÊý¤¬Àݼ褹¤Ù¤­¤Ê¤Î¤Ï¡Ö¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¡×¤Ç¤¢¤ê¡¢´°½Ï¥Ð¥Ê¥Ê¤ÏÃí°Õ¤¬É¬ÍפǤ¹¡£

¢£¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¤Ë´Þ¤Þ¤ì¤ë¡Ö¥ì¥¸¥¹¥¿¥ó¥È¥¹¥¿¡¼¥Á¡×¤ÎƯ¤­

¥ì¥¸¥¹¥¿¥ó¥È¥¹¥¿¡¼¥Á¤Ï¡¢¾®Ä²¤ÇµÛ¼ý¤µ¤ì¤ºÂçIJ¤Çȯ¹Ú¤µ¤ì¤ë¿©ÊªÁ¡°ÝÍͤÎÀ®Ê¬¤Ç¡¢°Ê²¼¤Î¤è¤¦¤ÊºîÍѤ¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡§

¡¦Ä²Æâ´Ä¶­¤Î²þÁ±¡ÊÁ±¶Ì¶Ý¤ÎÁý¿£¡¢Ã»º¿»éËûÀ¤Î»ºÀ¸¡Ë
¡¦¥¤¥ó¥¹¥ê¥ó´¶¼õÀ­¤Î¸þ¾å
¡¦´Î¡¤Ø¤Î»éËÃÃßÀѤò¸º¾¯
¡¦¿©¸å·ìÅüÃͤÎÍÞÀ©

ÆÃ¤Ë¡¢¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¤Ë´Þ¤Þ¤ì¤ëRS2·¿¥ì¥¸¥¹¥¿¥ó¥È¥¹¥¿¡¼¥Á¤Ï¡¢´Î»éËäθº¾¯¸ú²Ì¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

½Ðŵ¡§Ni Y, Zhuge F, Nagata N, et al. ¡ÈEffects of resistant starch supplementation on liver fat and metabolic markers in patients with NAFLD: a randomized controlled trial.¡É Clinical Nutrition. 2023;42(5):987-995.
¢ª ¤³¤ÎRCT¡ÊRandomized controlled trial¡Ë¤Ç¤Ï¡¢NAFLD´µ¼Ô¤ËRS2¤ò12½µ´ÖÅêÍ¿¤·¤¿¤È¤³¤í¡¢´Î»éËÃÎÌ¡¦¥¤¥ó¥¹¥ê¥óÄñ¹³À­¡¦±ê¾É¥Þ¡¼¥«¡¼¤¬Í­°Õ¤Ë²þÁ±¤·¤Þ¤·¤¿¡£

¢£¡Ö¥Ð¥Ê¥Ê¤ÏÂÀ¤ë¡×¤Ï¸í²ò¡©»éËôΤÎÊý¤ËÅÁ¤¨¤¿¤¤¥Ý¥¤¥ó¥È

¥Ð¥Ê¥Ê¤ÏGI¡Ê·ìÅü»Ø¿ô¡Ë¤¬Èæ³ÓŪ¹â¤¯¡¢²ÌÅü¤ò¿¤¯´Þ¤à¤¿¤á¡¢´°½Ï¥Ð¥Ê¥Ê¤òÂçÎ̤˿©¤Ù¤ë¤È»éËôΤò°­²½¤µ¤»¤ë¥ê¥¹¥¯¤¬¤¢¤ê¤Þ¤¹¡£

¤·¤«¤·¡¢°Ê²¼¤Î¤è¤¦¤ËÀݼ褹¤ë¤³¤È¤Ç¡¢¤à¤·¤í²þÁ±¸ú²Ì¤¬´üÂÔ¤µ¤ì¤Þ¤¹¡£

¡Ú»éËôΤοͤ¬¥Ð¥Ê¥Ê¤ò¿©¤Ù¤ëºÝ¤Î5¤Ä¤Î¥ë¡¼¥ë¡Û

1.̤½Ï¤Ê¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¤òÁª¤Ö¡Ê²Äǽ¤Ê¤éÎäÅà¤ÇÈÎÇ䤵¤ì¤Æ¤¤¤ëÀĥХʥʡË
2.1Æü1ËܤޤǤòÌܰ¤ˡ¢Ä«¡ÁÃë´Ö¤ËÀݼè
3.¤Ç¤­¤ì¤Ð¡¢Â¾¤Î¿©ÊªÁ¡°Ý¡Ê¥Ö¥í¥Ã¥³¥ê¡¼¡¢Æ¦Îà¤Ê¤É¡Ë¤È°ì½ï¤ËÀݤë
4.Ä´ÍýË¡¤Ï¾Æ¤«¤º¤Ë¡¢²ÃÇ®¤òÈò¤±¤Æ¤½¤Î¤Þ¤ÞÀݤë¡Ê²ÃÇ®¤ÇRS¤¬¸º¾¯¡Ë
5.´°½Ï¥Ð¥Ê¥Ê¡Ê¹õ¤¤ÈÃÅÀ¤¬¤¢¤ë¡Ë¤Ï¹µ¤¨¤á¤Ë

¢£ ¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê vs ¥µ¥×¥ê¥á¥ó¥È¤ÎRS¡§¤É¤Á¤é¤¬Îɤ¤¤«¡©

¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¤«¤éÀݼè¤Ç¤­¤ëRS¤Ï¼«Á³Í³Íè¤Ç¤¢¤ê¡¢ÉûºîÍѤ¬¾¯¤Ê¤¯¡¢Ä²Æâ¥Õ¥í¡¼¥é¤Î¿ÍÍÀ­¤ò¹â¤á¤ëÍøÅÀ¤¬¤¢¤ê¤Þ¤¹¡£

°ìÊý¡¢RS¤ò¥Ñ¥¦¥À¡¼²½¤·¤¿¡Ö¥ì¥¸¥¹¥¿¥ó¥È¥¹¥¿¡¼¥Á¥µ¥×¥ê¡×¤â¤¢¤ê¡¢¤è¤ê³Î¼Â¤ÊÀݼèÎÌ´ÉÍý¤¬²Äǽ¤Ç¤¹¡£¤¿¤À¤·¡§

¡¦¥µ¥×¥ê¤Ï²¼Î¡¡¦ËÄËþ´¶¤ò°ú¤­µ¯¤³¤·¤ä¤¹¤¯¡¢¾¯Î̤«¤é¤¬´ðËÜ
¡¦À®Ê¬¤Î¼Á¡¦Í³Íè¤Ë¤è¤Ã¤Æ¸ú²Ì¤Ëº¹¤¬¤¢¤ë¤¿¤á¡¢ÁªÄê¤ËÃí°Õ

¿©ÉʤȤ·¤Æ¤Î¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¤Ï¡¢¡ÖÀݼè¤Î½¬´·²½¡×¤¬¤·¤ä¤¹¤¤ÅÀ¤Ç¤âÍ­Íø¤Ç¤¹¡£

¢£¥Ð¥Ê¥Ê°Ê³°¤Ë¤â´Î¡¤ËÎɤ¤¿©Éʤϡ©

»éËôβþÁ±¤Î¤¿¤á¤Ë¤Ï¡¢ÄãGI¡¦¹â¿©ÊªÁ¡°Ý¡¦ÎɼÁ¤Ê¤¿¤ó¤Ñ¤¯¼Á¤ò´Þ¤à¿©ºà¤¬¿ä¾©¤µ¤ì¤Þ¤¹¡£

¡¦¥Ö¥í¥Ã¥³¥ê¡¼¡¢¥¢¥¹¥Ñ¥é¥¬¥¹¡¢»ÞƦ¤Ê¤É¤ÎÌîºÚ
¡¦Àĵû¡¢Íñ¡¢·Ü¤à¤ÍÆù¤Ê¤É¤Î¤¿¤ó¤Ñ¤¯¼Á¸»
¡¦È¯¹Ú¿©ÉÊ¡ÊǼƦ¡¦¥­¥à¥Á¡¦¥è¡¼¥°¥ë¥È¡Ë¤Ë¤è¤ëIJ³è

¤³¤ì¤é¤Ï¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¤ÈÁȤ߹ç¤ï¤»¤ÆÀݼ褹¤ë¤³¤È¤ÇÁê¾è¸ú²Ì¤¬´üÂÔ¤µ¤ì¤Þ¤¹¡£

¢£¤Þ¤È¤á¡§»éËôΤȥХʥʤδط¸¤Ï¡Ö½ÏÅ١פǷè¤Þ¤ë

»éËôΡá²ÌʪNG¤È¤¤¤¦¸í²ò¤Ïº¬¶¯¤¤¤Ç¤¹¤¬¡¢¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¤Ï¤à¤·¤í»éËôΤβþÁ±¤ËÍ­±×¤Ê¿©ÉʤǤ¹¡£

¡¦¥°¥ê¡¼¥ó¥Ð¥Ê¥Ê¤Ï¥ì¥¸¥¹¥¿¥ó¥È¥¹¥¿¡¼¥Á¤òË­É٤˴ޤߡ¢Ä²³è¡¦´Î»éËøº¾¯¤ËÍ­¸ú
¡¦½Ï¤·¤¹¤®¤¿¥Ð¥Ê¥Ê¤Ï·ìÅüÃͤòµÞ¾å¾º¤µ¤»¡¢´Î¡¤ËÉéô¤ò¤«¤±¤ë¤¿¤áÃí°Õ
¡¦¿©¤ÙÊý¡¦¥¿¥¤¥ß¥ó¥°¡¦ÁȤ߹ç¤ï¤»¤ËÇÛθ¤¹¤ì¤Ð¡Ö»éËôΤǤâ°Â¿´¤·¤Æ¿©¤Ù¤é¤ì¤ë²Ìʪ¡×

¡Ú»²¹Íʸ¸¥¡Û
Ni Y, Zhuge F, Nagata N, et al. Effects of resistant starch supplementation on liver fat and metabolic markers in patients with NAFLD: a randomized controlled trial. Clin Nutr. 2023;42(5):987-995.
Maziarz MP, Preisendanz S, Juma S, Imrhan V, Prasad C. Resistant starch lowers postprandial glucose and leptin in overweight adults consuming a moderate-fat diet: a randomized-controlled trial. Nutrition Journal. 2017;16(1):14.
Goff HD, Repin N, Fabek H, El Khoury D, Gidley MJ. Dietary fibre for glycaemia control and diabetes management. Current Opinion in Clinical Nutrition and Metabolic Care. 2018;21(6):471-478.

[ʸ¡§ÃÓ¿¬Âç¶¶¤»¤é¥¯¥ê¥Ë¥Ã¥¯±¡Ä¹¡¡À¤ÎÉ ÂÙ]

¢¨·ò¹¯¡¢¥À¥¤¥¨¥Ã¥È¡¢±¿Æ°Åù¤ÎÊýË¡¡¢¥á¥½¥Ã¥É¤Ë´Ø¤·¤Æ¤Ï¡¢¤¢¤¯¤Þ¤Ç¤â¼èºàÂоݼԤθĿÍŪ¤Ê°Õ¸«¡¢¥Î¥¦¥Ï¥¦¤Ç¡¢É¬¤º¸ú²Ì¤¬¤¢¤ë»ö¤òÊݾڤ¹¤ë¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£

ÃÓ¿¬Âç¶¶¤»¤é¥¯¥ê¥Ë¥Ã¥¯±¡Ä¹¡¦À¤ÎÉ Â١ʤ»¤é ¤ä¤¹¤·¡Ë

·ÄØæµÁ½ÎÂç³Ø°å³ØÉô´¡£½é´ü¸¦½¤¸å¡¢»ÔÃæÉ±¡¤Ë¤ÆÆâ²Ê¡¢À°·Á³°²Ê¤Î¿ÇÎŤäÃϰè¤Î±¿Æ°ÎÅË¡»ØÆ³¤Ê¤É¤ò¹Ô¤¦¡£¥¹¥Ý¡¼¥Ä°å³Ø¤ÎÎ×¾²¡¢¶µ°é¡¢¸¦µæ¤ò¹Ô¤¤¤Ê¤¬¤é¡¢¥×¥í¥¹¥Ý¡¼¥Ä¤ä¹â¹»Âç³Ø¡¢¼Ò²ñ¿Í¥¹¥Ý¡¼¥Ä¥Á¡¼¥à¤Î¥Á¡¼¥à¥É¥¯¥¿¡¼¤ª¤è¤Ó¶¥µ»ÃÄÂΤΰå»ö°Ñ°÷¤È¤·¤Æ³èư¡£±¿Æ°¤ä¥¹¥Ý¡¼¥Ä°å³Ø¤òÄ̤¸¤Æ¡¢Ï·¼ãÃ˽÷¿¤¯¤Î¿Í¡¹¤¬·ò¹¯¤ÇË­¤«¤ÊÀ¸³è¤¬Á÷¤ì¤ë¤è¤¦¤Ë¡¢¿ÇÎŤÀ¤±¤Ç¤Ê¤¯¥¹¥Ý¡¼¥Ä°å³Ø¤Ë´Ø¤¹¤ë¥³¥ó¥µ¥ë¥Æ¥£¥ó¥°¤ä»ÜÀߤΰåÎÅÂÎÀ©À°È÷¤Ê¤ÉÉý¹­¤¯³èư¤·¤Æ¤¤¤ë¡£